Zhu Y - Search Results

1

Associations between the expressions of MiR-135 and MiR-92a and pathogenesis of prostate cancer and analysis of their clinical significance.

He W, He H, Zhang N, Rui W, Wang X, Zhu Y, Xie X. He W, et al. Among authors: zhu y. J BUON. 2020 May-Jun;25(3):1619-1624. J BUON. 2020. PMID: 32862613 Free article.

2

Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (< or =1 cm): the Ruijin clinical experience in 88 patients.

Wang XJ, Shen ZJ, Zhu Y, Zhang RM, Shun FK, Shao Y, Rui WB, He W. Wang XJ, et al. Among authors: zhu y. BJU Int. 2010 Mar;105(6):849-53. doi: 10.1111/j.1464-410X.2009.08878.x. Epub 2009 Sep 14. BJU Int. 2010. PMID: 19751254

3

Heparanase-1 and Cyclooxygenase-2: prognostic indicators of malignancy in pheochromocytomas.

Zhu Y, He HC, Yuan F, Zhang J, Rui WB, Zhao JP, Shen ZJ, Ning G. Zhu Y, et al. Endocrine. 2010 Aug;38(1):93-9. doi: 10.1007/s12020-010-9356-y. Epub 2010 Jun 18. Endocrine. 2010. PMID: 20960108

4

Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma.

Zhu Y, He HC, Su TW, Wu YX, Wang WQ, Zhao JP, Shen Z, Zhang CY, Rui WB, Zhou WL, Sun FK, Ning G. Zhu Y, et al. Endocrine. 2010 Oct;38(2):254-9. doi: 10.1007/s12020-010-9381-x. Epub 2010 Jul 18. Endocrine. 2010. PMID: 21046486 Clinical Trial.

5

Predictive factors for malignant pheochromocytoma: analysis of 136 patients.

Feng F, Zhu Y, Wang X, Wu Y, Zhou W, Jin X, Zhang R, Sun F, Kasoma Z, Shen Z. Feng F, et al. Among authors: zhu y. J Urol. 2011 May;185(5):1583-90. doi: 10.1016/j.juro.2010.12.050. Epub 2011 Mar 21. J Urol. 2011. PMID: 21419457

6

Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.

Xu YZ, Zhu Y, Shen ZJ, Sheng JY, He HC, Ma G, Qi YC, Zhao JP, Wu YX, Rui WB, Wei Q, Zhou WL, Xie X, Ning G. Xu YZ, et al. Among authors: zhu y. Endocrine. 2011 Dec;40(3):445-51. doi: 10.1007/s12020-011-9502-1. Epub 2011 Jun 25. Endocrine. 2011. PMID: 21706269

7

Retroperitoneal adrenal-sparing surgery for the treatment of Cushing's syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients.

He HC, Dai J, Shen ZJ, Zhu Y, Sun FK, Shao Y, Zhang RM, Wang HF, Rui WB, Zhong S. He HC, et al. Among authors: zhu y. World J Surg. 2012 May;36(5):1182-1188. doi: 10.1007/s00268-012-1509-0. World J Surg. 2012. PMID: 22382766

8

Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence.

Zhao J, Zhu Y, Zhang C, Wang X, He H, Wang H, Wu Y, Zhou W, Shen Z. Zhao J, et al. Among authors: zhu y. Urol Oncol. 2013 Nov;31(8):1800-5. doi: 10.1016/j.urolonc.2012.04.019. Epub 2012 May 31. Urol Oncol. 2013. PMID: 22658883 Clinical Trial.

9

Ureteroscopic lithotripsy using holmium laser for 187 patients with proximal ureteral stones.

Liu DY, He HC, Wang J, Tang Q, Zhou YF, Wang MW, Chu CL, Zhang CY, Zhu Y, Zhou WL, Shen ZJ. Liu DY, et al. Among authors: zhu y. Chin Med J (Engl). 2012 May;125(9):1542-6. Chin Med J (Engl). 2012. PMID: 22800818

10

Myxoid adrenal cortical tumor: report of four cases.

Sheng JY, He HC, Zhu Y, Wu YX, Shen ZJ, Zhao JP, Ma G, Xu YZ. Sheng JY, et al. Among authors: zhu y. Chin Med J (Engl). 2012 May;125(9):1672-4. Chin Med J (Engl). 2012. PMID: 22800844 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,057 results

Search Page

Filters